Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Heinrich Joist

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Current Hematology Reports|August 7, 2003
Recombinant factor VIIa: a universal hemostatic agent?John V Lloyd, J Heinrich Joist
Journal of the Royal Society of Medicine|February 4, 2003
Apparent cellulitis with a prolonged APTT. Activated partial thromboplastin timeGanesh C Kudva, Murali Sundaram, J Heinrich Joist
Diabetes Research and Clinical Practice|May 17, 2005
Aspirin sensitivity of platelet aggregation in diabetes mellitusStewart G Albert, Bibi I Hasnain, Detlef G Ritter, et al.
Transfusion|March 16, 2002
Pharmacokinetic analysis of plasma-derived and recombinant F IX concentrates in previously treated patients with moderate or severe hemophilia BBruce M Ewenstein, J Heinrich Joist, Amy D Shapiro, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Current Hematology Reports|August 7, 2003
Recombinant factor VIIa: a universal hemostatic agent?John V Lloyd, J Heinrich Joist
Journal of the Royal Society of Medicine|February 4, 2003
Apparent cellulitis with a prolonged APTT. Activated partial thromboplastin timeGanesh C Kudva, Murali Sundaram, J Heinrich Joist
Diabetes Research and Clinical Practice|May 17, 2005
Aspirin sensitivity of platelet aggregation in diabetes mellitusStewart G Albert, Bibi I Hasnain, Detlef G Ritter, et al.
Transfusion|March 16, 2002
Pharmacokinetic analysis of plasma-derived and recombinant F IX concentrates in previously treated patients with moderate or severe hemophilia BBruce M Ewenstein, J Heinrich Joist, Amy D Shapiro, et al.
Pageof 1